J&J’s Orthopedics Unit Could Fetch $20 Billion — The Separation Math Is Tight
Apollo is reportedly among bidders for DePuy Synthes, a $9.3 billion-revenue business; the buyer must find growth and margin upside in a mature, regulated implant market.
What changed, why it matters, and what most people may be overlooking.
Apollo is reportedly among bidders for DePuy Synthes, a $9.3 billion-revenue business; the buyer must find growth and margin upside in a mature, regulated implant market.